Cocrystal pharma to present at the dawson james 2021 small cap growth conference on october 21, 2021

Bothell, wash., oct. 14, 2021 (globe newswire) -- cocrystal pharma, inc.  (nasdaq: cocp) (“cocrystal” or the “company”), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of coronaviruses, influenza, hepatitis c viruses and noroviruses, announces that management will present at the dawson james 2021 small cap growth conference on thursday, october 21, 2021 at 2:00 p.m. eastern time (10:00 a.m. pacific time). the conference is being held at the wyndham grand hotel in jupiter, fla.
COCP Ratings Summary
COCP Quant Ranking